<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03970395</url>
  </required_header>
  <id_info>
    <org_study_id>0074260</org_study_id>
    <nct_id>NCT03970395</nct_id>
  </id_info>
  <brief_title>Effectiveness of Osteopathic Manipulative Therapy in Nonsynostotic Plagiocephaly</brief_title>
  <official_title>Effectiveness of Osteopathic Manipulative Therapy in Nonsynostotic Plagiocephaly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PRIOLO CLAUDIO</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Scuola Superiore di Osteopatia Italiana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Ospedaliera Citt√† della Salute e della Scienza di Torino</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to evaluate the effectiveness of osteopathic manipulative therapy in&#xD;
      reducing the asymmetries of skull in infants with nonsynostotic plagiocephaly.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nonsynostotic plagiocephaly (NSP) is defined as the deformation of the head resulting from&#xD;
      external forces that mould the skull during the first months of life.&#xD;
&#xD;
      Four months seems to be a critical age for the development of NSP, but many positional head&#xD;
      shape deformities may improve with time.&#xD;
&#xD;
      Early assessment and diagnosis is important not only for the shape of the skull, but also for&#xD;
      possible clinical significant differences in gross motor development.&#xD;
&#xD;
      In paediatric conditions the effect of osteopathic manipulative treatment is documented in&#xD;
      systematic reviews; in NSP the only study, which is a pilot, reveals an average reduction of&#xD;
      50% asymmetry on 12 infants who have undergone a course of four osteopathic treatments.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Actual">February 26, 2020</completion_date>
  <primary_completion_date type="Actual">February 26, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A two arms randomized controlled trial. The experimental group will receive Osteopathic manipulative Therapy and the active comparator the Light Touch Therapy</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Infants were randomly assigned to two groups, OMT and LTT by using a random number generator, prepared in advance by an independent biostatistician. Sequentially numbered, opaque, and sealed envelopes were used.&#xD;
Clinician-Investigators, neonatology staff, the physical therapist, and the osteopath in charge of assessment were unaware of the random list.&#xD;
Infants' parents, after having signed the informed consent form, chose the numbered envelope and were unaware of the random list for the whole period of study.&#xD;
The two osteopaths in charge of Osteopathic manipulative therapy and Light Touch Therapy were unblinded to group assignment.&#xD;
Clinical outcomes were assessed by a biostatistician who was not involved in the patients' clinical allocation and management.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months</measure>
    <time_frame>Baseline and 3 months</time_frame>
    <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104 Nonsynostotic Plagiocephaly ODDI score &lt;104 Absence of Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 1 Year of Age.</measure>
    <time_frame>Follow-up at 1 year of age</time_frame>
    <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104 Nonsynostotic Plagiocephaly ODDI score &lt;104 Absence of Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months</measure>
    <time_frame>At 3 months</time_frame>
    <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104 Nonsynostotic Plagiocephaly ODDI score &lt;104 Absence of Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 1 Year of Age.</measure>
    <time_frame>Follow-up at one year of age</time_frame>
    <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of Nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104&lt;108 MILD Nonsynostotic Plagiocephaly ODDI score &gt;=108&lt;112 MODERATE Nonsynostotic Plagiocephaly ODDI score &gt;= 112 SEVERE Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cranial Proportion Index (CPI)</measure>
    <time_frame>The change of CPI will be measured at baseline, at 3 months from baseline and follow-up at 1 year of age.</time_frame>
    <description>Change of the width and length diameter measured with Plagiocephalometry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Event</measure>
    <time_frame>From first treatment (1 week post-baseline) up to end of treatment course (3 months).</time_frame>
    <description>Symptoms such as irritability accured after the Osteopathic Manipulative Therapy or Light Touch Therapy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Nonsynostotic Plagiocephaly</condition>
  <arm_group>
    <arm_group_label>Osteopathic manipulative therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Repositioning Therapy plus Osteopathic Manipulative Therapy (OMTh).&#xD;
Osteopathic Manipulative Therapy. Participant OMT group receive 6 OMTh in 3 months, as follows: first at baseline, the second after 1 week, the third after 3 weeks, and then once every 3 weeks for three more visits.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Light Touch Therapy</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Repositioning Therapy plus Light Touch Therapy (LTT)&#xD;
Participants to the LTT group receive the LTT protocol at the same date of the OMTh group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Osteopathic manipulative therapy (OMTh)</intervention_name>
    <description>The Osteopathic Manipulative Therapy includes evaluation and treatment. The evaluation considers the pelvic girdle and lower limb, thorax abdominal area, pectoral girdle and upper limbs, cervical and upper thoracic area, cranial vault, cranial base and viscero cranium. The treatment is based on balanced ligamentous tension technique, myofascial release, visceral manipulation, and balanced membranous tension technique. The OMTh lasts for 45 minutes of which 15 minutes of evaluation and 30 minutes of treatment.</description>
    <arm_group_label>Osteopathic manipulative therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Light Touch Therapy (LTT)</intervention_name>
    <description>The LTT is consistent with the OMT during the phase of evaluation. The treatment retains the same areas used for osteopathic approach but avoids prolonged touch in any area of the body, moving the hands every few seconds, and by flattening and softening the surface of the hands to minimize focal areas of force.</description>
    <arm_group_label>Light Touch Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Repositioning therapy</intervention_name>
    <description>It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;, by alternating head position, the use of tummy time while supervised, and the infants must spend minimal time in car seats or other devices that promote supine positions. In active counter-positioning the parents are suggested to place some toys on the side of the head where neck rotation is limited while, when using the changing table, to alternate the end of the table at which the infant's head is placed.</description>
    <arm_group_label>Light Touch Therapy</arm_group_label>
    <arm_group_label>Osteopathic manipulative therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Infants with NSP, ODDI score of 104% or more.&#xD;
&#xD;
          -  To be at term corrected age if born prematurely.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Synostotic Plagiocephaly&#xD;
&#xD;
          -  Infant who underwent an osteopathic manipulative treatment before the enrolment&#xD;
&#xD;
          -  Dysmorphisms&#xD;
&#xD;
          -  Syndromes&#xD;
&#xD;
          -  Congenital Muscular Torcicolis&#xD;
&#xD;
          -  Cerebral Palsy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudio G Priolo, Medical</last_name>
    <role>Study Director</role>
    <affiliation>Azienda Ospedaliera Citt√† della Salute e della scienza di Torino _ Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniele Farina, Medical</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Citt√† della Salute e della scienza di Torino _ Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Neonatology and NICU, Sant'Anna Hospital, Azienda Ospedaliera Universitaria Citt√† della Salute e della Scienza.</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Rogers GF. Deformational plagiocephaly, brachycephaly, and scaphocephaly. Part I: terminology, diagnosis, and etiopathogenesis. J Craniofac Surg. 2011 Jan;22(1):9-16. doi: 10.1097/SCS.0b013e3181f6c313. Review.</citation>
    <PMID>21187783</PMID>
  </reference>
  <reference>
    <citation>Rogers GF. Deformational plagiocephaly, brachycephaly, and scaphocephaly. Part II: prevention and treatment. J Craniofac Surg. 2011 Jan;22(1):17-23. doi: 10.1097/SCS.0b013e3181f6c342. Review.</citation>
    <PMID>21187782</PMID>
  </reference>
  <reference>
    <citation>Lennartsson F. Developing guidelines for child health care nurses to prevent nonsynostotic plagiocephaly: searching for the evidence. J Pediatr Nurs. 2011 Aug;26(4):348-58. doi: 10.1016/j.pedn.2010.07.003. Epub 2010 Sep 25.</citation>
    <PMID>21726785</PMID>
  </reference>
  <reference>
    <citation>Lessard S, Gagnon I, Trottier N. Exploring the impact of osteopathic treatment on cranial asymmetries associated with nonsynostotic plagiocephaly in infants. Complement Ther Clin Pract. 2011 Nov;17(4):193-8. doi: 10.1016/j.ctcp.2011.02.001. Epub 2011 Mar 5.</citation>
    <PMID>21982132</PMID>
  </reference>
  <reference>
    <citation>van Vlimmeren LA, Takken T, van Adrichem LN, van der Graaf Y, Helders PJ, Engelbert RH. Plagiocephalometry: a non-invasive method to quantify asymmetry of the skull; a reliability study. Eur J Pediatr. 2006 Mar;165(3):149-57. Epub 2005 Oct 7.</citation>
    <PMID>16211401</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>May 5, 2019</study_first_submitted>
  <study_first_submitted_qc>May 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <results_first_submitted>July 10, 2020</results_first_submitted>
  <results_first_submitted_qc>September 2, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 24, 2020</results_first_posted>
  <last_update_submitted>February 11, 2021</last_update_submitted>
  <last_update_submitted_qc>February 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Citt√† della Salute e della Scienza di Torino</investigator_affiliation>
    <investigator_full_name>PRIOLO CLAUDIO</investigator_full_name>
    <investigator_title>Paediatrician</investigator_title>
  </responsible_party>
  <keyword>Positional Plagiocephaly, Deformational Plagiocephaly,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Plagiocephaly</mesh_term>
    <mesh_term>Plagiocephaly, Nonsynostotic</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 19, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/95/NCT03970395/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Of the 129 infants screened at Sant'Anna Hospital, 96 were enrolled between September 2016 and June 2019.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Osteopathic Manipulative Therapy Plus Repositioning Therapy</title>
          <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Osteopathic Manipulative Therapy (OMTh).&#xD;
They received 6 OMTh in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopath with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
        </group>
        <group group_id="P2">
          <title>Light Touch Therapy Plus Repositioning Therapy</title>
          <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Light Touch Therapy (LTT).&#xD;
They received 6 LTT in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopath with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Osteopathic Manipulative Therapy Plus Repositioning Therapy</title>
          <description>Participants with Nonsynostic Plagiocephaly, Oblique Diameter Difference Index (ODDI )score &gt;= 104% were randomized to Repositioning Therapy plus Osteopathic Manipulative Therapy (OMTh).&#xD;
They received 6 OMTh in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
        </group>
        <group group_id="B2">
          <title>Light Touch Therapy Plus Repositioning Therapy</title>
          <description>Participants with Nonsynostic Plagiocephaly, Oblique Diameter Difference Index (ODDI) score &gt;= 104% were randomized to Repositioning Therapy plus Light Touch Therapy (LTT).&#xD;
They received 6 LTT in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="48"/>
            <count group_id="B3" value="96"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.1" spread="1.4"/>
                    <measurement group_id="B2" value="3.2" spread="1.6"/>
                    <measurement group_id="B3" value="3.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational Age</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.7" spread="3.9"/>
                    <measurement group_id="B2" value="34.3" spread="4.6"/>
                    <measurement group_id="B3" value="35.5" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Presentation at birth</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Cefalic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Breech</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Trasvers</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Birth weight</title>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2657" spread="945"/>
                    <measurement group_id="B2" value="2290" spread="995"/>
                    <measurement group_id="B3" value="2473" spread="970"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mother's first pregnancy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Multiple birth</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Delivery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Vaginal</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Assisted</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Vacuum - Forceps</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Cesarean</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Feeding</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Maternal</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Bottle</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mix</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sleeping</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Supine</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Variable</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Daytime</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Supine</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Variable</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mother's age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.8" spread="5.4"/>
                    <measurement group_id="B2" value="35.1" spread="6.5"/>
                    <measurement group_id="B3" value="34.45" spread="5.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Father's age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.9" spread="6.8"/>
                    <measurement group_id="B2" value="37.1" spread="6.8"/>
                    <measurement group_id="B3" value="37" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age end of study</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.1" spread="1.4"/>
                    <measurement group_id="B2" value="6.2" spread="1.6"/>
                    <measurement group_id="B3" value="6.15" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months</title>
        <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104 Nonsynostotic Plagiocephaly ODDI score &lt;104 Absence of Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
        <time_frame>Baseline and 3 months</time_frame>
        <population>Intent to Treat Population (all infants assigned to OMTh or LTT). Last observation carried forward (LOCF) imputation method.</population>
        <group_list>
          <group group_id="O1">
            <title>Osteopathic Manipulative Therapy Plus Repositioning Therapy</title>
            <description>Participants received Osteopathic Manipulative Therapy (OMTh) plus Repositioning Therapy.&#xD;
OMTh: 6 treatments in 3 months, first at baseline, second at 1 week, third at 3 weeks, and then 3 more at 3 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Light Touch Therapy Plus Repositioning Therapy</title>
            <description>Participants received Light Touch Therapy (LTT) plus Repositioning Therapy. LTT: 6 treatments in 3 months, first at baseline, second at 1 week, third at 3 weeks, and then 3 more at 3 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months</title>
          <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104 Nonsynostotic Plagiocephaly ODDI score &lt;104 Absence of Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
          <population>Intent to Treat Population (all infants assigned to OMTh or LTT). Last observation carried forward (LOCF) imputation method.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>ODDI score &lt;104%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ODDI score &gt;=104%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.01</p_value>
            <p_value_desc>The threshold for statistical significance was p&lt;0.5</p_value_desc>
            <method>Risk Ratio (RR)</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>7.66</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.46</ci_lower_limit>
            <ci_upper_limit>23.84</ci_upper_limit>
            <estimate_desc>Risk Difference 0.41 (IC 95; 0.25-0.53)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 1 Year of Age.</title>
        <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104 Nonsynostotic Plagiocephaly ODDI score &lt;104 Absence of Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
        <time_frame>Follow-up at 1 year of age</time_frame>
        <population>Intent to Treat Population (all infants assigned to OMTh or LTT). Last observation carried forward (LOCF) imputation method.</population>
        <group_list>
          <group group_id="O1">
            <title>Osteopathic Manipulative Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Osteopathic Manipulative Therapy (OMTh).&#xD;
They received 6 OMTh in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopaths with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Light Touch Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Light Touch Therapy (LTT).&#xD;
They received 6 LTT in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopaths with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 1 Year of Age.</title>
          <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104 Nonsynostotic Plagiocephaly ODDI score &lt;104 Absence of Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
          <population>Intent to Treat Population (all infants assigned to OMTh or LTT). Last observation carried forward (LOCF) imputation method.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>ODDI score &lt;104%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ODDI score &gt;=104%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Relative Risk (RR)</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>5.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.36</ci_lower_limit>
            <ci_upper_limit>13.27</ci_upper_limit>
            <estimate_desc>Risk Difference 0.47 (IC 95; 0.31-0.64)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months</title>
        <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104 Nonsynostotic Plagiocephaly ODDI score &lt;104 Absence of Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
        <time_frame>At 3 months</time_frame>
        <population>Per Protocol population, defined as participants completing the three months intervention.</population>
        <group_list>
          <group group_id="O1">
            <title>Osteopathic Manipulative Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Osteopathic Manipulative Therapy (OMTh).&#xD;
They received 6 OMTh in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopaths with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Light Touch Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Light Touch Therapy (LTT).&#xD;
They received 6 LTT in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopaths with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months</title>
          <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104 Nonsynostotic Plagiocephaly ODDI score &lt;104 Absence of Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
          <population>Per Protocol population, defined as participants completing the three months intervention.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>ODDI score &lt;104%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ODDI score &gt;=104%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Risk Ratio (RR)</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>7.49</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.42</ci_lower_limit>
            <ci_upper_limit>23.18</ci_upper_limit>
            <estimate_desc>Risk Difference 0.44 (IC 95%; 0.27-0.60)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 1 Year of Age.</title>
        <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of Nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104&lt;108 MILD Nonsynostotic Plagiocephaly ODDI score &gt;=108&lt;112 MODERATE Nonsynostotic Plagiocephaly ODDI score &gt;= 112 SEVERE Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
        <time_frame>Follow-up at one year of age</time_frame>
        <population>Per Protocol population, defined as participants completing the one year of age follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Osteopathic Manipulative Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Osteopathic Manipulative Therapy (OMTh).&#xD;
They received 6 OMTh in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopaths with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Light Touch Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Light Touch Therapy (LTT).&#xD;
They received 6 LTT in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopaths with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 1 Year of Age.</title>
          <description>The ODDI score being the most clinically relevant measure to define nonsynostotic plagiocephaly.&#xD;
The category of Nonsynostotic plagiocephaly is defined by reference to the following score:&#xD;
ODDI score &gt;=104&lt;108 MILD Nonsynostotic Plagiocephaly ODDI score &gt;=108&lt;112 MODERATE Nonsynostotic Plagiocephaly ODDI score &gt;= 112 SEVERE Nonsynostotic Plagiocephaly Higher score means a worse outcome.</description>
          <population>Per Protocol population, defined as participants completing the one year of age follow-up visit.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>ODDI score &lt;104%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ODDI score &gt;=104%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Risk Ratio (RR)</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>4.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.12</ci_lower_limit>
            <ci_upper_limit>11.38</ci_upper_limit>
            <estimate_desc>Risk Difference 0.54 (IC 95; 0.36-0.72)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cranial Proportion Index (CPI)</title>
        <description>Change of the width and length diameter measured with Plagiocephalometry.</description>
        <time_frame>The change of CPI will be measured at baseline, at 3 months from baseline and follow-up at 1 year of age.</time_frame>
        <population>Data were not collected for lack of clinical relevance</population>
        <group_list>
          <group group_id="O1">
            <title>Osteopathic Manipulative Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Osteopathic Manipulative Therapy (OMTh).&#xD;
They received 6 OMTh in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopaths with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Light Touch Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Light Touch Therapy (LTT).&#xD;
They received 6 LTT in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopaths with specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Cranial Proportion Index (CPI)</title>
          <description>Change of the width and length diameter measured with Plagiocephalometry.</description>
          <population>Data were not collected for lack of clinical relevance</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Event</title>
        <description>Symptoms such as irritability accured after the Osteopathic Manipulative Therapy or Light Touch Therapy</description>
        <time_frame>From first treatment (1 week post-baseline) up to end of treatment course (3 months).</time_frame>
        <population>Any Adverse Events</population>
        <group_list>
          <group group_id="O1">
            <title>Osteopathic Manipulative Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Osteopathic Manipulative Therapy (OMTh).&#xD;
They received 6 OMTh in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention were performed by two osteopaths with a specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Light Touch Therapy Plus Repositioning Therapy</title>
            <description>Participants with Nonsynostic Plagiocephaly, ODDI score &gt;= 104% were randomized to Repositioning Therapy plus Light Touch Therapy (LTT).&#xD;
They received 6 LTT in 3 months, as follows: first at baseline, second after 1 week, third after 3 weeks, and then three more visits every 3 weeks.&#xD;
The intervention was performed by two osteopaths with a specific background in paediatric field.&#xD;
Repositioning therapy: It consists of strategies that guide the parents to position the baby &quot;back to sleep&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Event</title>
          <description>Symptoms such as irritability accured after the Osteopathic Manipulative Therapy or Light Touch Therapy</description>
          <population>Any Adverse Events</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Serious Adverse events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other adverse events such as irritability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From first treatment (1 week post-baseline) up to end of treatment course (3 months).</time_frame>
      <desc>Symptoms such as irritability occured after the Osteopathic Manipulative Therapy or Light Touch Therapy</desc>
      <group_list>
        <group group_id="E1">
          <title>Osteopathic Manipulative Therapy Plus Repositioning Therapy</title>
          <description>Participants received Osteopathic Manipulative Therapy (OMTh) plus Repositioning Therapy.&#xD;
OMTh: 6 treatments in 3 months, first at baseline, second at 1 week, third at 3 weeks, and then 3 more at 3 weeks.</description>
        </group>
        <group group_id="E2">
          <title>Light Touch Therapy Plus Repositioning Therapy</title>
          <description>Participants received Light Touch Therapy (LTT) plus Repositioning Therapy. LTT: 6 treatments in 3 months, first at baseline, second at 1 week, third at 3 weeks, and then 3 more at 3 weeks.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Claudio G Priolo</name_or_title>
      <organization>Azienda Ospedaliera Citt√† della Salute e della scienza di Torino _ Italy</organization>
      <phone>0039 3471403064</phone>
      <email>claudiog.priolo@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

